Nexstim Plc (NXTMH.HE)

EUR 7.64

(9.46%)

EBITDA Summary of Nexstim Plc

  • Nexstim Plc's latest annual EBITDA in 2023 was -935.5 Thousand EUR , up 37.06% from previous year.
  • Nexstim Plc's latest quarterly EBITDA in 2024 Q2 was -466.5 Thousand EUR , down 0.0% from previous quarter.
  • Nexstim Plc reported an annual EBITDA of 1.61 Million EUR in 2022, up 85.32% from previous year.
  • Nexstim Plc reported an annual EBITDA of 842.64 Thousand EUR in 2021, up 201.16% from previous year.
  • Nexstim Plc reported a quarterly EBITDA of N/A for 2023 FY, up 37.06% from previous quarter.
  • Nexstim Plc reported a quarterly EBITDA of -1.07 Million EUR for 2023 Q2, down -100.02% from previous quarter.

Annual EBITDA Chart of Nexstim Plc (2023 - 2012)

Historical Annual EBITDA of Nexstim Plc (2023 - 2012)

Year EBITDA EBITDA Growth
2023 -935.5 Thousand EUR 37.06%
2022 1.61 Million EUR 85.32%
2021 842.64 Thousand EUR 201.16%
2020 -1.05 Million EUR 78.88%
2019 -4.74 Million EUR 6.49%
2018 -5.06 Million EUR 4.13%
2017 -5.25 Million EUR 16.97%
2016 -6.32 Million EUR 21.47%
2015 -8.05 Million EUR -13.51%
2014 -7.09 Million EUR -69.03%
2013 -4.19 Million EUR -81.55%
2012 -2.31 Million EUR 0.0%

Peer EBITDA Comparison of Nexstim Plc

Name EBITDA EBITDA Difference
BBS-Bioactive Bone Substitutes Oyj -3.14 Million EUR 70.298%
Modulight Oyj -10.44 Million EUR 91.043%
Revenio Group Oyj 30.09 Million EUR 103.109%